ProfileGDS4718 / 234095_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 68% 58% 36% 50% 58% 34% 26% 43% 57% 56% 50% 61% 42% 27% 34% 43% 37% 43% 33% 50% 53% 46% 56% 53% 48% 34% 58% 48% 65% 26% 28% 38% 49% 54% 33% 28% 34% 56% 48% 41% 48% 35% 37% 25% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.7194668
GSM549102patient 115, normal, homogenized [OPG study]6.023958
GSM549104patient 119, normal, homogenized [OPG study]4.8101536
GSM549108patient 138, normal, homogenized [OPG study]5.5316950
GSM549119patient 077, normal, homogenized [OPG study]5.9964258
GSM549133patient 032, cancer, homogenized [OPG study]4.6538734
GSM549139patient 042, cancer, homogenized [OPG study]4.3594526
GSM549099patient 107, normal, homogenized [OPG study]5.1596243
GSM549109patient 139, normal, homogenized [OPG study]5.9645957
GSM549110patient 046, normal, homogenized [OPG study]5.8544956
GSM549114patient 063, normal, homogenized [OPG study]5.462150
GSM549122patient 082, normal, homogenized [OPG study]6.1921761
GSM549134patient 033, cancer, homogenized [OPG study]5.0740342
GSM549136patient 036, cancer, homogenized [OPG study]4.3746127
GSM549140patient 044, cancer, homogenized [OPG study]4.6720834
GSM549111patient 047, normal, homogenized [OPG study]5.1283543
GSM549113patient 057, normal, homogenized [OPG study]4.8145137
GSM549132patient 031, cancer, homogenized [OPG study]5.1432543
GSM549137patient 038, cancer, homogenized [OPG study]4.6642933
GSM549142patient 047, cancer, homogenized [OPG study]5.6668550
GSM549100patient 110, normal, homogenized [OPG study]5.6888453
GSM549107patient 135, normal, homogenized [OPG study]5.2592546
GSM549115patient 068, normal, homogenized [OPG study]5.8097556
GSM549116patient 072, normal, homogenized [OPG study]5.700353
GSM549120patient 078, normal, homogenized [OPG study]5.4156348
GSM549131patient 030, cancer, homogenized [OPG study]4.6636134
GSM549118patient 074, normal, homogenized [OPG study]6.0119958
GSM549129patient 027, cancer, homogenized [OPG study]5.4468448
GSM549123patient 088, normal, homogenized [OPG study]6.5046965
GSM549124patient 006, cancer, homogenized [OPG study]4.4183526
GSM549126patient 015, cancer, homogenized [OPG study]4.4268128
GSM549128patient 025, cancer, homogenized [OPG study]4.8967338
GSM549103patient 117, normal, homogenized [OPG study]5.5265849
GSM549117patient 073, normal, homogenized [OPG study]5.6849954
GSM549138patient 041, cancer, homogenized [OPG study]4.6607133
GSM549141patient 045, cancer, homogenized [OPG study]4.3938628
GSM549130patient 028, cancer, homogenized [OPG study]4.750934
GSM549101patient 111, normal, homogenized [OPG study]5.9045356
GSM549105patient 128, normal, homogenized [OPG study]5.4439748
GSM549106patient 134, normal, homogenized [OPG study]4.9706941
GSM549112patient 048, normal, homogenized [OPG study]5.3797148
GSM549125patient 011, cancer, homogenized [OPG study]4.7628635
GSM549127patient 024, cancer, homogenized [OPG study]4.8304637
GSM549135patient 035, cancer, homogenized [OPG study]4.3018425